Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model

Microvascular Research

Volumn 77, Issue 2, 2009, Pages 96-103

  Hendriksen, E M ^a   Span, P N ^a   Schuuring, J ^b   Peters, J P W ^a   Sweep, F C G J ^a   van der Kogel, A J ^a   Bussink, J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GROENE HART HOSPITAL   (Netherlands)

Author keywords

Angiogenesis; Glioblastoma multiforme; HIF 1 ; Hypoxia; Microenvironment; Pimonidazole; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VASCULARIZATION; XENOGRAFT;

ANIMALS; ANOXIA; BLOOD VESSELS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 60549104814     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.11.002     Document Type: Article

References (49)

1. Arbiser J.L., Moses M.A., Fernandez C.A., Ghiso N., Cao Y., Klauber N., Frank D., Brownlee M., Flynn E., Parangi S., Byers H.R., and Folkman J. Oncogenic H-ras stimulates tumour angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 861-866
2. Bernsen H.J.J.A., Rijken P.F.J.W., Oostendorp T., and van der Kogel A.J. Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. Br. J. Cancer 71 (1995) 721-726
3. Bouck N. Tumour angiogenesis: the role of oncogenes and tumour suppressor genes. Cancer Cells 2 6 (1990) 179-185
4. Bussink J., Kaanders J.H.A.M., Rijken P.F.J.W., Peters J.W.P., Hodgkiss R.J., Marres H.A.M., and van der Kogel A.J. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide. Radiother. Oncol. 50 (1999) 173-184
5. Bussink J., Kaanders J.H., Strik A.M., Vojnovic B., and van Der Kogel A.J. Optical sensorbased oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines. Radiat. Res. 154 5 (2000) 547-555
6. Cao Y., Li C.Y., Moeller J.B., Yu D., Zhao Y., Dreher M.R., Shan S., and Dewhirst M.W. Observation of incipient tumour angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res. 65 13 (2005) 5498-5505
7. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 69 Suppl.3 (2005) 4-10
8. Dewhirst M.W., Ong E.T., Braun R.D., Smith B., Klitzman B., Evans S.M., and Wilson D. Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br. J. Cancer 79 11-12 (1999) 1717-1722
9. Fenton B.M., Paoni S.F., Beauchamp B.K., and Ding I. Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis. Br. J. Cancer 86 (2002) 1831-1836
10. Folkman J. Tumour angiogenesis: therapeutic implications. N. Engl. J. Med. 285 (1971) 1182-1186
11. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumours. Ann. Surg. 175 (1972) 409-416
12. Folkman J., Watson K., Ingber D., and Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339 (1989) 5-61
13. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
14. Grebenschikov N., Geurts-Moespot A., Witte H., de Heuvel J., Leake R., Sweep F., and Benraad T. A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitors type 1 (PAI-1) in breast tumour cytosols. Int. J. Biol. Markers 12 1 (1997) 6-14
15. Gorski D.H., Beckett M.A., Jaskowiak N.T., Calvin D.P., Mauceri H.J., Salloum R.M., Seetharam S., Koons A., Hari D.M., Kufe D.W., and Weichselbaum R.R. Blockage of the vascular endothelial growth factor stress response increases the antitumour effects of ionizing radiation. Cancer Res. 59 (1999) 3374-3378
16. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell 86 3 (1996) 353-364
17. Heinzman J.M., Brower S.L., and Bush J.E. Comparison of angiogenesis-related factor expression in primary tumor cultures under normal and hypoxic growth conditions. Cancer Cell Int. 8 11 (2008)
18. Jain R.K. Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nat. Rev. Cancer 8 4 (2008) 309-316
19. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R.K., and Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425
20. Konerding M.A., Malkusch W., Klapthor B., van Ackern C., Fait E., Hill S.A., Parkins C., Chaplin D.J., Presta M., and Denekamp J. Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br. J. Cancer 80 (1999) 724-732
21. Konerding M.A., Fait E., and Gaumann A. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br. J. Cancer 84 10 (2001) 1354-1362
22. Leek R.D., Hunt N.C., Landers R.J., Lewis C.E., Royds J.A., and Harris A.L. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190 (2000) 430-436
23. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., and Nuseir N. Macrophageinduced angiogenesis is mediated by tumour necrosis factoralpha. Nature 329 (1987) 630-632
24. Levy A.P., Levy N.S., and Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271 (1996) 2746-2753
25. Li C.Y., Shan S., Huang Q., Braun R.D., Lanzen J., Hu K., Lin P., and Dewhirst M.W. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J. Natl. Cancer Inst. 92 (2000) 143-147
26. Li X.F., Carlin S., Urano M., Russell J., Ling C.C., O, and ' Donoghue J.A. Visualization of hypoxia in microscopic tumours by immunofluorescent microscopy. Cancer Res. 67 16 (2007) 7646-7653
27. Ljungkvist A.S.E., Bussink J., Rijken P.F.J.W., Kaanders J.H.A.M., van der Kogel A.J., and Denekamp J. Vascular architecture, hypoxia and proliferation in first generation xenografts of human head-and-neck squamous cell carcinomas. In. J. Radiat. Oncol. Biol. Phys. 54 1 (2002) 215-228
28. Mancuso M.R., Davis R., Norberg S.M., O'Brien S., Sennino B., Nakahara T., Yao V.J., Inai T., Brooks P., Freimark B., Shalinsky D.R., Hu-Lowe D.D., and McDonald D.M. Rapid vascular regrowth in tumours after reversal of VEGF inhibition. J. Clin. Invest. 116 10 (2006) 2610-2621
29. Måseide K., and Rofstad E.K. Intratumour heterogeneity in microvessel oxyhaemoglobin saturations. Cancer lett. 162 2 (2001) 245-251
30. Mizukami Y., Li J., Zhang X., Zimmer M.A., Iliopoulos O., and Chung D.C. Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res. 64 (2004) 1765-1772
31. Mizukami Y., Fujiki K., Duerr E.M., Gala M., Jo W.S., Zhang X., and Chung D.C. Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-Kinase/Rho/ROCK and c-Myc. J. Biol. Chem. 281 20 (2006) 13957-13963
32. Moeller B.J., Cao Y., Li C.Y., and Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumours: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 (2004) 429-441
33. Padera T.P., and Jain R.K. VEGFR3: a new target for antiangiogenesis therapy?. Dev Cell. 15 2 (2008) 178-179
34. Pathak A.P., Hochfeld W.E., Goodman S.L., and Pepper M.S. Circulating and Imaging Markers for Angiogenesis (2008), Springer, Netherlands online, 17-10-2008
35. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9 (2003) 677-684
36. Pore N., Liu S., Shu H.K., Li B., Haas-Kogan D., Stokoe D., Milanini-Mongiat J., Pages G., O ' Rourke D.M., Bernhard E., and Maity A. Sp1 is involved in Akt mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell. 15 (2004) 4841-4853
37. Pötgens A.J.G., Lubsen N.H., Van Altena M.C., Schoenmakers J.C.G., Ruiter D.J., and De Waal R.M.W. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am. J. Pathology 146 (1995) 197-209
38. Raleigh J.A., Chou S.C., Arteel G.E., and Horsman M.R. Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H mouse tumours. Radiat. Res. 151 (1999) 580-589
39. Riedel F., Gotte K., Goessler U., Sadick H., and Hormann K. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines. Anticancer Res. 24 (2004) 2179-2183
40. Rijken P.F.J.W., Bernsen H.J.J.A., and van der Kogel A.J. Application of an image analysis system to the quantitation of tumour perfusion and vascularity in human glioma xenografts. Microvasc. Res. 50 (1995) 141-153
41. Rijken P.F.J.W., Bernsen H.J.J.A., Peters J.P.W., Hodgkiss R.J., Raleigh J.A., and van der Kogel A.J. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 571-582
42. Rijken P.F.J.W., Peters J.P.W., and van der Kogel A.J. Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines. Radiat. Res. 157 (2002) 626-632
43. Scott P.A., Gleadle J.M., Bicknell R., and Harris A.L. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int. J. Cancer 75 (1998) 706-712
44. Secomb T.W., Hsu R., Ong E.T., Gross J.F., and Dewhirst M.W. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumours. Acta Oncol. 34 (1995) 313-316
45. Span P.N., Grebenschikov N., Geurts-Moespot J., Westphal J.R., Lucassen A.M.J., and Sweep C.G.J. EORTC Receptor and Biomarker Study Group report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumour tissue extracts. Int. J. Biol. Markers 15 2 (2000) 184-191
46. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
47. Tang N., Wang L., Esko J., Giordano F.J.M., Huang Y., Gerber H.P., Ferrara N., and Johnson R.S. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumourigenesis. Cancer Cell 6 5 (2004) 485-495
48. Vaupel P., and Mayer A. Hypoxia and anemia: effects on tumour biology and treatment resistance. Transfus. Clin. Biol. 12 (2005) 5-10
49. Westphal J.R., Van 't Hullenaar R.G.M., and Van der Laak J.A.W.M. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br. J. Cancer 76 (1997) 561-570